Abstract

A 65-year-old women was diagnosed with acute myeloid leukemia (AML; normal cytogenetics, NPM1 mutated, FLT3-ITD wild type). Preinduction screening geriatric assessment (GA) did not reveal any significant deficit, because she was independent of basic activities of daily living (ADLs) and instrumental activities of daily living (IADLs), had normal cognition, and scored 10 (range 0-12) on the short physical performance battery (SPPB). She underwent standard 7 + 3 induction and achieved a complete remission, although her course was complicated by neutropenic sepsis and bacteremia. She is being evaluated for postremission therapy. Would you recommend a follow-up GA at this time?

References

References
1.
Klepin
HD
,
Wildes
TM
.
Geriatric oncology: getting even better with age
.
J Am Geriatr Soc
.
2019
;
67
(
5
):
871
-
872
.
2.
Loh
KP
,
Klepin
HD
.
Geriatric assessment in acute myeloid leukemia: current and future landscape
.
Blood Adv
.
2018
;
2
(
18
):
2418
.
3.
DuMontier
C
,
Liu
MA
,
Murillo
A
, et al
.
Function, survival, and care utilization among older adults with hematologic malignancies
.
J Am Geriatr Soc
.
2019
;
67
(
5
):
889
-
897
.
4.
Muffly
LS
,
Kocherginsky
M
,
Stock
W
, et al
.
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
.
Haematologica
.
2014
;
99
(
8
):
1373
-
1379
.
5.
Abel
GA
,
Klepin
HD
.
Frailty and the management of hematologic malignancies
.
Blood
.
2018
;
131
(
5
):
515
-
524
.
6.
Hill
A
,
Sadda
J
,
LaBarge
MA
,
Hurria
A
.
How cancer therapeutics cause accelerated aging: insights from the hallmarks of aging [published online ahead of print 21 March 2019]
.
J Geriatr Oncol
.
doi:10.1016/j.jgo.2019.03.007
.
7.
Williams
AM
,
Zent
CS
,
Janelsins
MC
.
What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research
.
Br J Haematol
.
2016
;
174
(
6
):
835
-
846
.
8.
Mohile
SG
,
Epstein
RM
,
Hurria
A
, et al
.
Improving communication with older patients with cancer using geriatric assessment (GA): a University of Rochester NCI Community Oncology Research Program (NCORP) cluster randomized controlled trial (CRCT)
.
2018
;
36
(
suppl 18
):
72018
.
9.
Klepin
HD
,
Tooze
JA
,
Pardee
TS
, et al
.
Effect of intensive chemotherapy on physical, cognitive, and emotional health of older adults with acute myeloid leukemia
.
J Am Geriatr Soc
.
2016
;
64
(
10
):
1988
-
1995
.
10.
Saad
MH
,
Tooze
JA
,
Pardee
TS
, et al
. The Short Physical Performance Battery (SPPB) score predicts survival among older adults with acute myeloid leukemia (AML) who have achieved remission. In: Proceedings from the American Geriatrics Society Annual Meeting; 18 May
2017
, 2017; San Antonio, TX. Abstract B138.
11.
Loh
KP
,
Tooze
JA
,
Nicklas
BJ
, et al
.
Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia [published online ahead of print 5 April 2019]
.
J Geriatr Oncol
.
doi:10.1016/j.jgo.2019.03.014
.
12.
Alibhai
SM
,
Breunis
H
,
Timilshina
N
, et al
.
Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age
.
J Geriatr Oncol
.
2015
;
6
(
4
):
262
-
271
.
13.
Bonanad
S
,
De la Rubia
J
,
Gironella
M
, et al
;
GAH Group
.
Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: the GAH Scale
.
J Geriatr Oncol
.
2015
;
6
(
5
):
353
-
361
.
14.
Cruz-Jentoft
AJ
,
González
B
,
de la Rubia
J
, et al
;
GAH Group
.
Further psychometric validation of the GAH scale: responsiveness and effect size
.
J Geriatr Oncol
.
2017
;
8
(
3
):
211
-
215
.
15.
Deschler
B
,
Ihorst
G
,
Schnitzler
S
,
Bertz
H
,
Finke
J
.
Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis
.
Bone Marrow Transplant
.
2018
;
53
(
5
):
565
-
575
.
16.
Goede
V
,
Stauder
R
.
Multidisciplinary care in the hematology clinic: implementation of geriatric oncology
.
J Geriatr Oncol
.
2019
;
10
(
3
):
497
-
503
.
You do not currently have access to this content.